Close Menu

Whole-genome sequencing is still very expensive, but it is being used to make a difference in the lives of patients with rare diseases, says Richard Knox at the NPR Shots blog. Clinicians were able to treat Alexis and Noah Beery — 14-year-old twins afflicted with a rare disease called dopa-responsive dystonia — with a simple and effective therapy for their disease after they underwent whole-genome sequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.